Atlas Trials

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Clinical trial NCT00299988 · TERMINATED

Trial details

NCT number
NCT00299988
Sponsor
Weill Medical College of Cornell University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2006-02-01
Primary completion
2009-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.